These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5811396)

  • 21. Synthesis and antihypertensive activity of 5-O-substituted derivatives of 5-hydroxypicolinic acid.
    Hachisu M; Tsuruoka T; Takahashi H; Asaoka H; Sekizawa Y; Koeda T; Inouye S
    J Pharmacobiodyn; 1983 Dec; 6(12):922-31. PubMed ID: 6674478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure decreased by halobutylpicolinic acid, an inhibitor of dopamine beta-hydroxylase.
    Hidaka H; Takeya K
    Nature; 1972 Oct; 239(5371):334-5. PubMed ID: 12635227
    [No Abstract]   [Full Text] [Related]  

  • 23. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: Fusaric acid derivatives: the effect on dopamine beta-hydroxylase.
    Umezawa H; Takeuchi T; Miyano K; Koshigoe K; Hamano H
    J Antibiot (Tokyo); 1973 Mar; 26(3):189. PubMed ID: 4205877
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of fusaric (5-butylpicolinic) acid on the monosynaptic reflex neural activity of cat spinal cord.
    Watanabe Y; Matsumiya T; Oka T
    Tokai J Exp Clin Med; 1981 Oct; 6(4):443-51. PubMed ID: 7324082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacology of N-propyl-ajmaline bromide (NPAB)].
    Gendenshteĭn EI
    Farmakol Toksikol; 1970; 33(3):303-5. PubMed ID: 5453025
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacological studies of fusaric acid. I. (author's transl)].
    Matsuzaki M; Onodera K; Okazaki I; Kishimoto K; Nakajima A
    Jpn J Antibiot; 1976 Apr; 29(4):403-18. PubMed ID: 933334
    [No Abstract]   [Full Text] [Related]  

  • 28. [Accumulation of fusaric acid by different species of fungi of the genus Fusarium and their phytotoxic properties].
    Polovinko GP
    Mikrobiol Zh (1978); 1979; 41(5):504-8. PubMed ID: 530122
    [No Abstract]   [Full Text] [Related]  

  • 29. Fusaric acid derivatives and analogues as possible antihypertensive drugs. Note I.
    Runti C; de Nardo M; Ulian F
    Farmaco Sci; 1981 Apr; 36(4):260-8. PubMed ID: 7250360
    [No Abstract]   [Full Text] [Related]  

  • 30. Relative inhibition of insect phenoloxidase by cyclic fungal metabolites from insect and plant pathogens.
    Dowd PF
    Nat Toxins; 1999; 7(6):337-41. PubMed ID: 11122526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies on toxicity of fusaric acid-Ca. III. Subacute toxicity in dogs (author's transl)].
    Matsuzaki M; Yoshida A; Tsuchida M; Sekino M; Asano M
    Jpn J Antibiot; 1976 May; 29(5):491-517. PubMed ID: 933339
    [No Abstract]   [Full Text] [Related]  

  • 32. Toxicological approaches to the metabolites of Fusaria. 3. Acute toxicity of fusarenon-X.
    Ueno Y; Ueno I; Iitoi Y; Tsunoda H; Enomoto M
    Jpn J Exp Med; 1971 Dec; 41(6):521-39. PubMed ID: 5316765
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on toxicity of fusaric acid-Ca. IV. Chronic toxicity in dogs (author's transl)].
    Matsuzaki M; Yoshida A; Akutsu S; Tsuchida M; Okuyama D
    Jpn J Antibiot; 1976 May; 29(5):518-42. PubMed ID: 933340
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of 13C in biosynthetic studies. Incorporation of isotopically labeled acetate and aspartate into fusaric acid.
    Desaty D; McInnes AG; Smith DG; Vining LC
    Can J Biochem; 1968 Oct; 46(10):1293-300. PubMed ID: 5701230
    [No Abstract]   [Full Text] [Related]  

  • 35. Toxicological approaches to the metabolites of Fusaria. II. Isolation of fusarenon-X from the culture filtrate of Fusarium nivale Fn 2B.
    Ueno Y; Ueno I; Amakai K; Ishikawa Y; Tsunoda H
    Jpn J Exp Med; 1971 Dec; 41(6):507-19. PubMed ID: 5316764
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacology of barium nitrosylpentacyanoferrate.
    Pham-Huu-Chanh ; Lecointe P; Donnat L
    Arzneimittelforschung; 1969 Nov; 19(11):1836-42. PubMed ID: 4391790
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacological study on kasugamycin].
    Matsuzaki A; Yoshida A; Onodera K; Sekino M; Tado N; Asano M
    Jpn J Antibiot; 1968 Aug; 21(4):206-20. PubMed ID: 5304357
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antihypertensive effect of trifluoropentoxypicolinic acid: a pharmacokinetic study].
    Horisaka K; Masuda S
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):301-7. PubMed ID: 6745810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings: Effect of fusaric acid and its derivatives on ethanol induced sleep of mice, stress induced gastric ulcer and blood pressure of rats.
    Harada N; Hashizume Y; Hidaka H
    Jpn J Pharmacol; 1974; 24(0):s:77. PubMed ID: 4545629
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of fusaric acid on the membrane potential in left ventricle fragments from rats and rabbits.
    Richter R
    Pharmazie; 1982 Oct; 37(10):736. PubMed ID: 7178221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.